Newly approved cancer drugs in China — innovation and clinical benefit
Crossref DOI link: https://doi.org/10.1038/s41571-023-00728-3
Published Online: 2023-01-16
Published Print: 2023-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yichen
Wagner, Anita K.
Guan, Xiaodong http://orcid.org/0000-0002-1290-3827
Text and Data Mining valid from 2023-01-16
Version of Record valid from 2023-01-16
Article History
First Online: 16 January 2023
Competing interests
: The authors declare no competing interests.